As of March 15, 2023, Seychelles was the African country with the highest coronavirus (COVID-19) vaccination rate, with around 205 doses administered per 100 individuals. Mauritius and Rwanda followed with 201 and 190 doses per 100 people, respectively. Ranking fourth, Morocco had a vaccination rate of approximately 148 doses per 100 people, registering the third-highest number of inoculations after Egypt and Nigeria. In South Africa, the most affected country on the continent, the vaccination rate instead reached around 64 per 100 population.

How did Africa obtain the vaccines?

Vaccines in Africa were obtained in different ways. African nations both purchased new doses and received them from other countries. At the beginning of the vaccination campaigns, donations came from all over the world, such as China, the United Arab Emirates, India, and Russia. The United Nations-led COVAX initiative provided Oxford/AstraZeneca and Pfizer/BioNTech doses to several African countries. Within this program, the continent received nearly 270 million doses as of January 2022. Moreover, the vaccination campaign has also been an occasion for intra-African solidarity. Senegal has, for instance, donated vaccines to the Gambia, while in January 2021, Algeria announced that it would have shared its supply with Tunisia.

COVID-19 impact on the African economy

The spread of COVID-19 negatively affected socio-economic growth in Africa, with the continent’s Gross Domestic Product (GDP) contracting significantly in 2020. Specifically, Southern Africa experienced the sharpest decline, at minus six percent, followed by North Africa at minus 1.7 percent. Most of Africa’s key economic sectors were hit by the pandemic. The drop in global oil prices led to a crisis in the oil and gas sector. Nigeria, the continent’s leading oil-exporting country, witnessed a considerable decrease in crude oil trade in 2020. Moreover, the shrinking number of international tourist arrivals determined a loss of over 12 million jobs in Africa’s travel and tourism sector. Society has also been substantially affected by COVID-19 on the poorest continent in the world, and the number of people living in extreme poverty was estimated to increase by around 30 million in 2020.

As of July 4, 2022, Africa had administered around 41 doses of coronavirus (COVID-19) vaccines per 100 people. The vaccination rate in the continent was far slower than the world average, measured at 154 vaccines per 100 individuals on the same date. The vaccination in Africa has also been marked by a striking divide between countries. Africa started receiving vaccine supplies under the WHO-backed Covax facility in February 2021. Some African countries purchased additional doses, while others benefited from bilateral donations.

Around **** percent of Africa's population was fully vaccinated against the coronavirus (COVID-19) as of July 11, 2022. Over *** million vaccine doses have been administered on the continent since the beginning of the vaccination campaign in 2021. In general, Africa's vaccination rate is far lower than the global average.

The number of COVID-19 vaccination doses administered per 100 people in South Africa rose to 65 as of Oct 27 2023. This dataset includes a chart with historical data for South Africa Coronavirus Vaccination Rate.

The average for 2022 based on 47 countries was 75 percent. The highest value was in Mauritius: 98 percent and the lowest value was in Angola: 37 percent. The indicator is available from 1980 to 2022. Below is a chart for all countries where data are available.

As of November 17, 2022, Egypt had administered around 100 million coronavirus (COVID-19) vaccination doses, the highest number in Africa. Second in the ranking, Nigeria distributed ** million vaccines against the virus. South Africa, which accumulated the highest number of COVID-19 cases in the continent, carried out roughly ** million immunizations.

Africa still behind in the vaccination campaign

While *** doses of the COVID-19 vaccine have been administered per 100 people in the world, the vaccination rate in Africa is ** doses per 100 individuals. Besides being far slowest than the global average, the vaccination is marked by a striking divide between African countries. In February 2021, Africa started receiving vaccine supplies under the WHO-backed Covax facility. Additionally, some African nations purchased additional doses, while others were benefited from bilateral donations.

High acceptance of the coronavirus vaccine

While the COVID-19 vaccination still needs to gain pace in Africa, the majority of the continent’s population was willing to take a vaccine against the disease. According to a survey, nearly ** percent of Africans would get vaccinated, once the immunizing is considered safe and effective. However, one in four people believed a COVID-19 vaccine would be unsafe. Over *** million people in Africa were already infected by the virus since the beginning of the pandemic in March 2020.

This dataset provides values for CORONAVIRUS VACCINATION RATE reported in several countries. The data includes current values, previous releases, historical highs and record lows, release frequency, reported unit and currency.

As of April 25, 2022, Mauritius was the African country with the highest coronavirus (COVID-19) booster vaccine rate, as ** percent of its population had received a booster shot. Seychelles and Rwanda followed, with booster vaccination rates of ** percent and ** percent, respectively.

Percentage of target population vaccinated with the first dose of HPV vaccine in WHO African Region countries.

BackgroundThe COVID-19 vaccination is regarded as an effective intervention for controlling the pandemic. However, COVID-19 vaccine hesitancy is hampering efforts geared towards reducing the burden of the pandemic. Therefore, examining COVID-19 hesitancy and its predictors among healthcare workers is essential to improving COVID-19 uptake. In sub-Saharan Africa, the pooled proportion of COVID-19 vaccine hesitancy is yet to be known.PurposeThe present study was to estimate the pooled proportion of COVID-19 vaccine hesitancy and its predictors among healthcare workers in Sub-Saharan Africa.MethodsA systematic search of articles was conducted in PubMed, Science Direct, African Journal Online, and Google Scholar. Data was extracted with the help of Excel. Data analysis was conducted using STATA 17. Heterogeneity in the studies was assessed using Cochrane Q and 12 tests. A random effects model was used to examine the pooled estimates to determine if heterogeneity was exhibited.ResultsA total of 15 studies involving 7498 participants were included in the final analysis. The pooled prevalence of COVID-19 vaccination hesitancy among healthcare workers was 46%, 95% CI (0.38–0.54). The predictors of COVID-19 hesitancy were negative beliefs towards vaccine 14.0% (OR = 1.05, 95% CI: 1.04, 1.06), perceived low risk of COVID-19 infection 24.0% (OR = 1.25, 95% CI: 1.23, 1.28), and vaccine side effects 25.0% (OR = 1.23, 95% CI: 1.21, 1.24).ConclusionThe data revealed generally high hesitancy of COVID-19 vaccine among health workers in Sub-Saharan Africa. Future COVID-19 adoption and uptake should be improved by national and individual level efforts. In Sub-Saharan Africa, it is crucial to address the myths and obstacles preventing healthcare professionals from accepting the COVID-19 vaccination as soon as feasible since their willingness to get the vaccine serves as an important example for the broader public.

The percentage of the target population vaccinated with a WHO-prequalified Measles Containing Vaccines (MCV) vaccine, reflecting immunization efforts and population immunity.

Time series data for the statistic Immunization, measles (% of children ages 12-23 months) and country South Africa. Indicator Definition:Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.The indicator "Immunization, measles (% of children ages 12-23 months)" stands at 76.00 as of 12/31/2024, the lowest value since 12/31/2011. Regarding the One-Year-Change of the series, the current value constitutes a decrease of -5.00 percent compared to the value the year prior.The 1 year change in percent is -5.00.The 3 year change in percent is -12.64.The 5 year change in percent is -8.43.The 10 year change in percent is -9.52.The Serie's long term average value is 76.26. It's latest available value, on 12/31/2024, is 0.343 percent lower, compared to it's long term average value.The Serie's change in percent from it's minimum value, on 12/31/2003, to it's latest available value, on 12/31/2024, is +22.58%.The Serie's change in percent from it's maximum value, on 12/31/2021, to it's latest available value, on 12/31/2024, is -12.64%.

Actual value and historical data chart for Central African Republic Immunization Measles Percent Of Children Ages 12 23 Months

As of 2022, around ** percent of people in Africa had received the third dose of the Hepatitis B vaccination. In comparison to that, around ** percent of people have received the third dose of the HepB vaccination globally.

The percentage of the target population vaccinated with a WHO-prequalified Measles Containing Vaccines (MCV) vaccine, reflecting immunization efforts and population immunity.

Immunization against DPT of South Africa slumped by 7.06% from 85.0 % in 2022 to 79.0 % in 2023. Since the 2.38% rise in 2021, immunization against DPT dropped by 8.14% in 2023. Child immunization measures the percentage of children ages 12-23 months who received vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.

South Africa ZA: Immunization: DPT: % of Children Aged 12-23 Months data was reported at 66.000 % in 2016. This records a decrease from the previous number of 75.000 % for 2015. South Africa ZA: Immunization: DPT: % of Children Aged 12-23 Months data is updated yearly, averaging 73.500 % from Dec 1983 (Median) to 2016, with 34 observations. The data reached an all-time high of 82.000 % in 2007 and a record low of 65.000 % in 2012. South Africa ZA: Immunization: DPT: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s South Africa – Table ZA.World Bank: Health Statistics. Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Public knowledge on COVID-19 vaccinations (n = 365).

Central African Republic CF: Immunization: Measles: % of Children Aged 12-23 Months data was reported at 41.000 % in 2023. This stayed constant from the previous number of 41.000 % for 2022. Central African Republic CF: Immunization: Measles: % of Children Aged 12-23 Months data is updated yearly, averaging 41.500 % from Dec 1980 (Median) to 2023, with 44 observations. The data reached an all-time high of 82.000 % in 1990 and a record low of 12.000 % in 1980. Central African Republic CF: Immunization: Measles: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Central African Republic – Table CF.World Bank.WDI: Social: Health Statistics. Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.;WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).;Weighted average;

The vaccines are considered to be important for the prevention and control of coronavirus disease 2019 (COVID-19). However, considering the limited vaccine supply within an extended period of time in many countries where COVID-19 vaccine booster shot are taken and new vaccines are developed to suppress the mutation of virus, designing an effective vaccination strategy is extremely important to reduce the number of deaths and infections. Then, the simulations were implemented to study the relative reduction in morbidity and mortality of vaccine allocation strategies by using the proposed model and actual South Africa's epidemiological data. Our results indicated that in light of South Africa's demographics, vaccinating older age groups (>60 years) largely reduced the cumulative deaths and the “0–20 first” strategy was the most effective way to reduce confirmed cases. In addition, “21–30 first” and “31–40 first” strategies have also had a positive effect. Partial vaccination resulted in lower numbers of infections and deaths under different control measures compared with full vaccination in low-income countries. In addition, we analyzed the sensitivity of daily testing volume and infection rate, which are critical to optimize vaccine allocation. However, comprehensive reduction in infections was mainly affected by the vaccine proportion of the target age group. An increase in the proportion of vaccines given priority to “0–20” groups always had a favorable effect, and the prioritizing vaccine allocation among the “60+” age group with 60% of the total amount of vaccine consistently resulted in the greatest reduction in deaths. Meanwhile, we observed a significant distinction in the effect of COVID-19 vaccine allocation policies under varying priority strategies on relative reductions in the effective reproduction number. Our results could help evaluate to control measures performance and the improvement of vaccine allocation strategy for COVID-19 epidemic.